Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome

Nephrology Dialysis Transplantation

Volumn 26, Issue 1, 2011, Pages 178-184

  Cammas, Benoît ^a,d   Harambat, Jérôme ^a   Bertholet Thomas, Aurélia ^b   Bouissou, François ^c   Morin, Denis ^d   Guigonis, Vincent ^e   Bendeddouche, Salih ^f   Afroukh Hacini, Nawel ^g   Cochat, Pierre ^b   Llanas, Brigitte ^a   Decramer, Stéphane ^c   Ranchin, Bruno ^b  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

^e LIMOGES UNIVERSITY HOSPITAL   (France)

^f Ctr Hosp Universitaire de Tlemcen   (Algeria)

^g CENTRE HOSPITALIER DE VALENCE   (France)

Author keywords

cyclophosphamide; growth; idiopathic nephrotic syndrome; steroids

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE; STEROID;

ARTICLE; BODY HEIGHT; BODY MASS; CHILD; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RELAPSE; REMISSION; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; CHILD, PRESCHOOL; COHORT STUDIES; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; NEPHROTIC SYNDROME; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME; TIME FACTORS; TREATMENT OUTCOME;

EID: 78650650741     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq405     Document Type: Article

References (25)

1. Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 1978; 13: 159-165
2. Niaudet P. Steroid-sensitive nephrotic syndrome in children. In: Avner ED, Harmon WE, Niaudet P (eds). Pediatric Nephrology. Philadelphia: Lippincott Williams and Wilkins, 2004; 543-556
3. Hodson EM, Craig JC, Willis NS. Evidence-based management of steroid-sensitive nephrotic syndrome. Pediatr Nephrol 2005; 20: 1523-1530
4. Barratt TM, Soothill JF. Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet 1970; 2: 479-482
5. Hodson EM, Willis NS, Craig JC. Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database Syst Rev 2008; 1: CD002290
6. Latta K, von Schnakenburg C, Ehrich JH. A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 2001; 16: 271-282
7. British Association for Paediatric Nephrology Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. Lancet 1991; 337: 1555-1557
8. Ponticelli C, Edefonti A, Ghio L et al. Cyclosporin versus cyclophos-phamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Nephrol Dial Transplant 1993; 3: 1326-1333
9. Ishikura K, Ikeda M, Hattori S et al. Effective and safe treatment with cyclosporine in nephrotic children: a prospective, randomized multi-center trial. Kidney Int 2008; 73: 1167-1173
10. Dorresteijn EM, Kist-van Holthe JE, Levtchenko EN et al. Mycophe-nolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome. Pediatr Nephrol 2008; 23: 2013-2020
11. Gellermann J, Querfeld U. Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil. Pediatr Nephrol 2004; 19: 101-104
12. Guigonis V, Dallocchio A, Baudouin Vet al. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol 2008; 23: 1269-1279
13. Vester U, Kranz B, Zimmermann S et al. Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook. Pediatr Nephrol 2003; 18: 661-664
14. Bérard E, Broyer M, Dehennault M et al. Pediatric Society of Nephrology. Corticosensitive nephrotic syndrome (or nephrosis) in children. Therapeutic guideline proposed by the Pediatric Society of Nephrology. Nephrol Ther 2005; 1: 150-156
15. Sempé M, Pédron G, Roy-Pernot MP. Auxologie méthode et séquences. Théraplix Paris 1979
16. Rolland-Cachera MF, Cole TJ, Sempé M et al. Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 1991; 45: 13-21
17. Kyrieleis HA, Levtchenko EN, Wetzels JF. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome. Am J Kidney Dis 2007; 49: 592-597
18. Watson AR, Rance CP, Bain J. Long term effects of cyclophospha-mide on testicular function. Br Med J (Clin Res Ed) 1985; 291: 1457-1460
19. Fakhouri F, Bocquet N, Taupin P et al. Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis 2003; 41: 550-557
20. Kabuki N, Okugawa T, Hayakawa H et al. Influence of age at onset on the outcome of steroid-sensitive nephrotic syndrome. Pediatr Nephrol 1998; 12: 467-470
21. Emma F, Sesto A, Rizzoni G et al. Long-term linear growth of children with severe steroid-responsive nephrotic syndrome. Pediatr Nephrol 2003; 18: 783-788
22. Foote KD, Brocklebank JT, Meadow SR. Height attainment in children with steroid-responsive nephrotic syndrome. Lancet 1985; 2: 917-919
23. Lam CN, Arneil GC. Long-term dwarfing effects of corticosteroid treatment for childhood nephrosis. Arch Dis Child 1968; 43: 589-594
24. Kano K, Nishikura K, Hoshi M. Linear growth of low-dose cyclosporin A therapy in children with steroid-dependent nephrotic syndrome. Nephron 2001; 87: 293-294
25. Berns JS, Gaudio KM, Krassner LS et al. Steroid-responsive neph-rotic syndrome of childhood: a long-term study of clinical course, histopathology, efficacy of cyclophosphamide therapy, and effects on growth. Am J Kidney Dis 1987; 9: 108-114